VDA inhibitor DMXAA, Purity ≥98%

Cat. No.: X23-10-ZQ500

VDA inhibitor DMXAA, Purity ≥98%

Synonym: Vadimezan; DMXAA; 117570-53-3; 5,6-Mexaa; 2-(5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid; 5,6-Dimethylxantheonone-4-acetic acid; AS-1404; ASA404; VDA inhibitor

  • MDL: MFCD00870555
  • CAS Number: 117570-53-3
  • Compound CID: 123964
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
DMXAA, soluble in DMSO and insoluble in ethanol and water, promptly disrupts the tumor's vascular network, leading to the death of tumor cells reliant on these blood vessels. It targets DT-diaphorase and DT diaphorase.
Molecular Weight
282.3
Molecular Formula
C17H14O4
Targets
DT-diaphorase: 20 μM (Ki); DT diaphorase: 20 μM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 7 mg/mL (24.79 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
DMXAA can be used to study its anti-tumor properties and its role in cancer therapy as an antivascular agent.
Storage
Store at -20ºC.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.